Back to Search
Start Over
Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma
- Source :
- Radiation Oncology, Vol 14, Iss 1, Pp 1-8 (2019), Radiation Oncology (London, England)
- Publication Year :
- 2019
- Publisher :
- Springer Science and Business Media LLC, 2019.
-
Abstract
- Background Patients with regional lymph node recurrence after radical resection of esophageal cancer have poor therapeutic outcomes. Currently, there is no standard treatment for regional lymph node recurrence, and its prognostic risk factors are not well-understood. This study retrospectively analyzed 83 patients with postoperative regional lymph node recurrence after radical resection of esophageal squamous cell carcinoma. The aim was to evaluate the clinical efficacy and prognostic factors of salvage radiotherapy with or without chemotherapy in these patients. Methods The survival and prognostic factors of 83 patients with esophageal squamous cell carcinoma with regional lymph node recurrence after radical surgery were retrospectively analyzed. All patients underwent radiotherapy, of which 74 patients received volumetric modulated arc therapy (VMAT), 9 patients received three-dimensional conformal radiation therapy (3DCRT), administered using a conventional segmentation protocol with a dose distribution range of 50.4–66.2Gy (median dose of 60Gy). In total, 41 patients received radiotherapy alone, 42 received radiotherapy combined with chemotherapy, and the concurrent chemotherapy regimen was mainly composed of either platinum or fluorouracil monotherapy, except for 4 patients who were given 5-fluorouracil plus platinum (FP) or paclitaxel plus platinum (TP). Results The median follow-up time was 24 (range, 9–75) months. The overall survival (OS) rates at 1 year, 2 years, 3 years, and 5 years were 83.0, 57.1, 40.1, and 35.1%, respectively. The median overall survival (OS) time was 18 (range, 5–75) months. The 3-year survival rate was 47.5% in patients with radiation alone and 41.9% in patients receiving concurrent chemoradiotherapy(p = 0.570), while the response rate (CR + PR) in those two groups was 73.2 and 91.4%, respectively. By multivariate analysis of OS, age (worse in younger patients, p = 0.034) was found to be significantly associated with disease prognosis. The commonly toxicities were esophagitis, neutropenia and anemia. 18% patients experienced grade 3 toxicity and no treatment-related death occurred. Conclusions These results of this retrospective analysis suggest that radiotherapy with or without chemotherapy is an effective and feasible salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
- Subjects :
- Male
Esophageal Neoplasms
medicine.medical_treatment
Radical surgery
0302 clinical medicine
Antineoplastic Combined Chemotherapy Protocols
Lymph node
Standard treatment
Chemoradiotherapy
Middle Aged
Lymph node recurrence
Esophageal cancer
Prognosis
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Survival Rate
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Female
030211 gastroenterology & hepatology
Fluorouracil
Radiology
Adult
lcsh:Medical physics. Medical radiology. Nuclear medicine
medicine.medical_specialty
Paclitaxel
lcsh:R895-920
lcsh:RC254-282
03 medical and health sciences
Esophageal squamous cell carcinoma
medicine
Humans
Radiology, Nuclear Medicine and imaging
Survival rate
Aged
Retrospective Studies
Salvage Therapy
Radiotherapy
business.industry
Research
medicine.disease
Esophagectomy
Radiation therapy
Regimen
Lymph Nodes
Radiotherapy, Intensity-Modulated
Cisplatin
Neoplasm Recurrence, Local
business
Subjects
Details
- ISSN :
- 1748717X
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Radiation Oncology
- Accession number :
- edsair.doi.dedup.....30bc2b14e8b6281d56becdc9dbeb9b30
- Full Text :
- https://doi.org/10.1186/s13014-019-1377-y